Joice Thomas

Title: Joice Thomas: Innovator in Opioid Receptor Antagonists

Introduction

Joice Thomas is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of pharmacology, particularly in the development of opioid receptor antagonists. Her innovative work has the potential to impact the treatment of opioid addiction and pain management.

Latest Patents

Joice Thomas holds a patent for her work on opioid receptor antagonists. The patent details the development of the first selective sulfur-fluoride exchange (SuFEx) antagonists to μ-opioid receptors (MOR). This groundbreaking research involved functionalizing an opioid scaffold with an SO—F warhead. The model she developed, based on a MOR structure with antagonist β-FNA, indicates that the naloxone carbonyl is an advantageous point for derivatization. This point is chemically accessible and does not interact with receptors. Among the three accessible Tyr residues in the MOR pocket, Tyr150 was selected as a target due to its proximity to the carbonyl of the docked naloxone, leading to the creation of highly potent antagonists.

Career Highlights

Joice Thomas is affiliated with the University of Southern California, where she continues her research and development in pharmacology. Her work has garnered attention for its innovative approach to addressing the challenges associated with opioid receptors.

Collaborations

Joice collaborates with Vsevolod Katritch, who is also involved in research related to opioid receptors. Their partnership enhances the depth and breadth of their research efforts.

Conclusion

Joice Thomas is a trailblazer in the field of opioid receptor antagonists, with her innovative patent showcasing her expertise and dedication to advancing pharmacological research. Her contributions are poised to make a significant impact on the treatment of opioid-related conditions.